GranBio is biotech company, pioneer in transforming cellulosic biomass into high-value chemical intermediates and biofuels. We were amongst the first to crack the code for cellulosic potential with over 10,000 hours of operation that prove our technology's efficacy in turning a wide range of biomass - including forest, agricultural and sugarcane residues - into biomaterials that help decarbonize hard-to-abate sectors and revitalize rural economies. Founded in 2011, we create, develop, demonstrate, and license state-of-the-art biotechnologies, with an option of EPC (Engineering, Procurement and Construction), in alliance with strategic partners. We have over 400 granted and pending patents in the bioeconomy field, reflecting our commitment to innovation and sustainability, and are scaling up production to 1-billion-gallons SAF by 2040 to meet growing global demand. For more information, please visit www.granbio.com.

300 McIntosh Parkway

Thomaston, GA 30286

USA